BRAF and melanoma: In our previous study, we reported [15] GNF-7 and its derivative SIJ1227 capable of strongly inhibiting melanoma cells with class I (A375)/class II (C8161) BRAF mutations and lung cancer cells with class II (H1755)/class III (H1666) BRAF mutations.